Healthcare - Biotechnology - NASDAQ - US
$ 0.8181
-3.24 %
$ 5.65 M
Market Cap
-0.53
P/E
INCOME STATEMENT
0
REVENUE
-7.69 M
OPERATING INCOME
-7.85 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Hoth Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 7.69 M |
| Operating Income | -7.69 M |
| Other Expenses | 153 K |
| Net Income | -7.85 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0 | 66.8 K | 46.9 | 25.9 K | 31.6 K | 28.3 K | 188 |
| Gross Profit | 0 | 66.8 K | (46.9) | 25.9 K | 31.6 K | 28.3 K | 188 |
| OPERATING INCOME | |||||||
| Operating Expenses | 7.7 | 11.1 | 14.1 | 7.3 | 7.7 | 2.5 | 1.9 |
| Selling, General and Administrative Expenses | 4.2 | 6.1 | 6.6 | 4.0 | 5.1 | 1.2 | 1.3 |
| Research and Development Expenses | 3.5 | 4.9 | 7.5 | 2.9 | 2.1 | 1.0 | 0.6 |
| Operating Income | (7.7) | (11.1) | (14.1) | (7.3) | (7.7) | (2.5) | (1.9) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | 0.3 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (0.2) | (0.3) | (0.2) | 0.1 | 10.4 K | 0 | (0.1) |
| Pre-Tax Income | (7.8) | (11.4) | (14.3) | (7.2) | (7.7) | (2.5) | (2.0) |
| NET INCOME | |||||||
| Tax Provision | 0 | 0.3 | 1.04 | (0.2) | 10.4 K | (0.2) | 2 |
| Net Income | (7.8) | (11.7) | (14.3) | (7.2) | (7.7) | (2.5) | (2.0) |
| EPS | 2.3 | 9.75 | 16 | 14.6 | 21 | 6.62 | 5.24 |